Literature DB >> 24252562

Immunolocalization of cell cycle proteins (p57, p27, cyclin D3, PCNA and Ki67) in intrauterine growth retardation (IUGR) and normal human term placentas.

Gozde Unek1, Asli Ozmen1, Murat Ozekinci2, Mehmet Sakinci2, Emin Turkay Korgun3.   

Abstract

Placental development involves a series of events that depend on the coordinated action of proliferation, differentiation and invasion of trophoblasts. Studies on cell cycle related proteins controlling these events are fairly limited. It is still not fully determined how placental tissue proliferation is affected by intrauterine growth retardation (IUGR). Information on cell cycle related proteins that control these events is limited and how they are affected in IUGR is not fully understood. The aim of this study was to understand the role of cell cycle regulators in IUGR placentas and to determine the spatio-temporal immunolocalization of these cell cycle regulators in human IUGR and normal term placentas. Placental samples were stained immunohistochemically with PCNA, Ki67, cyclin D3, p27 and p57 antibodies and were examined by light microscopy. In all regions of IUGR placentas, PCNA, Ki67 and cyclin D3 staining intensities were statistically significantly decreased compared to normal controls. p27 staining intensity of the IUGR group was statistically significantly increased in villous parts and chorionic plates in comparison with the normal term placentas. Moreover, p57 staining intensity was statistically significantly increased in all parts of the IUGR group compared to controls. The observed placental abnormalities in IUGR placentas may be associated with arrest mechanisms affecting cell proliferation and cell cycle alterations in IUGR.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cyclin D3; IUGR; Ki67; PCNA; Placenta; p27; p57

Mesh:

Substances:

Year:  2013        PMID: 24252562     DOI: 10.1016/j.acthis.2013.10.007

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  2 in total

1.  Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.

Authors:  Tetsuro Yoshimaru; Masato Komatsu; Etsu Tashiro; Masaya Imoto; Hiroyuki Osada; Yasuo Miyoshi; Junko Honda; Mitsunori Sasa; Toyomasa Katagiri
Journal:  Sci Rep       Date:  2014-12-08       Impact factor: 4.379

2.  Analysis of CDKN1C in fetal growth restriction and pregnancy loss.

Authors:  Jenifer P Suntharalingham; Miho Ishida; Gudrun E Moore; John C Achermann; Federica Buonocore; Ignacio Del Valle; Nita Solanky; Charalambos Demetriou; Lesley Regan
Journal:  F1000Res       Date:  2019-01-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.